Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
Recruiting · NCT06255210 · Registry updated 2024-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON) | Esthesioneuroblastoma, Olfactory, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, cranial nerve neuropathy, epithelial neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, olfactory nerve disorder, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2024-02-13 | NCT06255210 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hongmeng Yu | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Eye & ENT Hospital of Fudan University | Shanghai | China | 17 |